Baillie Gifford & Co
NPSP

Baillie Gifford & Co’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Baillie Gifford & Co’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-25,173
Closed -$801K – 223
2013
Q3 		$801K Hold
25,173
– – ﹤0.01% 175
2013
Q2 		$380K Buy
+25,173
New +$349K ﹤0.01% 151

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co's NPSP Position: Q4 2013 in Review

Baillie Gifford & Co sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2013, closing a stake of 25,173 shares — an estimated $801K sold.

Baillie Gifford & Co first reported a position in NPSP in Q2 2013 and held it in 2 quarters. The position peaked at $801K in Q3 2013. 191 funds tracked by Wall St. Rank hold NPSP as of Q4 2013.

  • Baillie Gifford & Co reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Baillie Gifford & Co sold 25,173 NPS PHARMACEUTICALS INC shares in Q4 2013, an estimated $801K.
  • Baillie Gifford & Co first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Baillie Gifford & Co's NPS PHARMACEUTICALS INC position peaked at $801K in Q3 2013.
  • 191 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2013.

Based on Baillie Gifford & Co's 13F filing for Q4 2013, filed 7 Feb 2014.